COVID-19 vaccination status in ASEAN

The latest status on the vaccination programmes in the ASEAN countries, including the doses administered and the types of vaccines used.

Many countries have kicked off their COVID-19 vaccination programme, including most ASEAN countries. As of mid-March 2021, out of the over 400 million vaccine doses administered worldwide, ASEAN countries have administered close to 9 million doses. The latest reported data shows that Indonesia currently holds the lead in the region, with over 6.5 million vaccine doses administered. On the other hand, Brunei has yet to report any doses. AstraZeneca’s vaccine, under the COVAX program, is the most popular in the region, forming at least part of the vaccination programme in 8 ASEAN countries, with Sinovac coming in second. Singapore is the only ASEAN country to go with the Pfizer-BioNTech and Moderna vaccines.

Doses administered % of population Vaccine
Per 100 people Total Vaccinated Fully vaccinated  
Singapore 14 792,423 9.70% 4.30% Pfizer, Moderna
Indonesia 2.5 6,581,388 1.80% 0.70% Sinovac, AZ
Malaysia 1.1 346,508 1.10% Sinovac, AZ
Cambodia 1.1 170,659 1.10% Sinovac, AZ
Myanmar 0.7 380,000 0.70% AZ
Laos 0.6 40,732 0.60% Sinovac
Philippines 0.2 215,997 0.20% Sinovac, AZ
Thailand 0.1 53,842 0.10% Sinovac, AZ
Vietnam <0.1 24,054 <0.1% AZ

Note: Some countries do not provide data for the number of people who have been partially or fully vaccinated.

The data is compiled from government sources by the New York Times’ Our World in Data project at the University of Oxford. A vaccinated person refers to someone who has received at least one dose of a vaccine, and a fully vaccinated person has received all required doses of a vaccine. For the Pfizer-BioNTech vaccine, a person who is “fully vaccinated” has received two doses.


As of 19 March 2021

Photo by CDC on Unsplash

Like this story? Subscribe for more

More Insights

June 3, 2021
Vietnam’s Cho Ray Hospital shares how setting up a dedicated audit team has ensured safety and epidemic prevention regulations compliance.
June 3, 2021
Hospital Management Asia speaks to Mr Kon Gryllakis, Head, Diagnostics at Siemens Healthineers Asia Pacific on the role that COVID-19 serology testing - the testing for antibodies against the COVID-19 virus – plays in measuring efficacy of vaccine response, and how serology testing can drive future public health policies.
June 3, 2021
Hospitals and clinics in Singapore conducting COVID-19 tests are using this set of interoperable standards which ensures reports are tamper-proof.